Cannuflow

Cannuflow is a long-established, privately-held player in the orthopedic medical device space, focusing exclusively on fluid management for arthroscopic surgery. Its product portfolio, including the ClearVu, TwoVu, and EntreVu EX systems, is designed to address specific surgical challenges such as extravasation, fogging, and poor visualization, thereby facilitating a shift from three-portal to two-portal techniques. The company appears to be commercially focused, generating revenue through direct sales of its FDA-cleared devices, and supports its value proposition with a body of clinical research on its website. Its outlook is tied to the growth of minimally invasive arthroscopy and the adoption of its efficiency-enhancing technologies by orthopedic surgeons.

Integrated fluid management systems for arthroscopic surgery, featuring outflow-enabled scope sheaths, combination instrument cannulas, and ancillary devices to control joint distension, visualization, and fluid extravasation.

Cannuflow competes in the niche fluid management segment against product lines from major orthopedic companies like Arthrex, Stryker, and Smith & Nephew, as well as other specialized device firms. Its differentiation is a deep focus on integrated systems designed specifically to enable efficient two-portal arthroscopy.